Dolphin Pharmatech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-07-2024
- Paid Up Capital ₹ 0.10 M
as on 05-07-2024
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 52.07%
(FY 2023)
- Profit 628.14%
(FY 2023)
- Ebitda 649.23%
(FY 2023)
- Net Worth 52.55%
(FY 2023)
- Total Assets 77.95%
(FY 2023)
About Dolphin Pharmatech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Vishal Shah, Namrata Shah, Poojaben Patel, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290GJ2018PTC101104
- Company No.
101104
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Mar 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Dolphin Pharmatech Private Limited offer?
Dolphin Pharmatech Private Limited offers a wide range of products and services, including Ayurvedic,Herbal Products & Medicine, Ayurvedic Medicine.
Who are the key members and board of directors at Dolphin Pharmatech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vishal Shah  | Director | 07-Mar-2018 | Current |
| Namrata Shah | Director | 07-Mar-2018 | Current |
| Poojaben Patel | Director | 07-Mar-2018 | Current |
| Nishantkumar Patel | Director | 07-Mar-2018 | Current |
Financial Performance of Dolphin Pharmatech.
Dolphin Pharmatech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 52.07% increase. The company also saw a substantial improvement in profitability, with a 628.14% increase in profit. The company's net worth Soared by an impressive increase of 52.55%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dolphin Pharmatech?
In 2023, Dolphin Pharmatech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dolphin Laser Tech Private LimitedActive 7 years 2 monthsVishal Shah, Namrata Shah and 2 more are mutual person
Dolphin Green Energy Private LimitedActive 5 years 3 monthsVishal Shah and Nishantkumar Patel are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dolphin Pharmatech?
Unlock and access historical data on people associated with Dolphin Pharmatech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dolphin Pharmatech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dolphin Pharmatech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
